Results last 23 months without maintenance, then gradually fade as your body's natural melanin production returns
Therefore, despite being only a partial effector of carcinogenesis, CBS belongs to a panel of intervening players, including NF-B, KRAS, p53 and Wnt components, that contribute to metabolic rewiring and increased proliferative and invasive potential
Finally, economic evaluations are necessary to assess cost-effectiveness and accessibility in clinical practice
Future diagnostic strategies should prioritize the development and validation of multimodal biomarker panels that integrate complementary pathophysiological information from metabolic, inflammatory, and neurotrophic pathways, as such panels are expected to outperform single biomarkers in sensitivity, specificity, and their ability to guide personalized therapeutic interventions for DPN
February 2, 2026: FDA Published Second Safety Label Change of 2026 for Zepbound Eli Lillys popular weight-loss drug Zepbound had a second safety label update in January 2026
10.1038/s41598-020-71510-z 141 ZhangY.ZhangY.HanY.TianY.WuP.XinA.et al (2020b)
